Aspen Pharmacare Statistics
Want to see APNHY full AI Analyst Report?
Aspen Pharmacare (APNHY) Stock Statistics & Valuation Metrics
Total Valuation
Aspen Pharmacare has a market cap or net worth of $4.43B. The enterprise value is $4.22B.
- Market Cap
- $4.43B
- Enterprise Value
- $4.22B
Share Statistics
Aspen Pharmacare has 432,921,450 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 432,921,450
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
Aspen Pharmacare’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 5.43%.
- Return on Equity (ROE)
- 0.03
- Return on Assets (ROA)
- 0.02
- Return on Invested Capital (ROIC)
- 5.43%
- Return on Capital Employed (ROCE)
- 0.06
- Revenue Per Employee
- 4.48M
- Profits Per Employee
- 339.92K
- Employee Count
- 7,625
- Asset Turnover
- 0.32
- Inventory Turnover
- 1.47
Valuation Ratios
The current PE Ratio of Aspen Pharmacare is 29.96. Aspen Pharmacare’s PEG ratio is -0.60.
- PE Ratio
- 29.96
- PS Ratio
- 2.22
- PB Ratio
- 0.99
- Price to FCF
- 16.35
- Price to Operating Cash Flow
- 11.53
- PEG Ratio
- -0.60
Income Statement
In the last 12 months, Aspen Pharmacare had revenue of 34.14B and earned 2.59B in profits. Earnings per share was 5.79.
- Revenue
- 34.14B
- Gross Profit
- 13.76B
- Operating Income
- 5.29B
- Pretax Income
- -409.30M
- Net Income
- 2.59B
- EBITDA
- 7.16B
- Earnings Per Share (EPS)
- 5.79
Cash Flow
In the last 12 months, operating cash flow was 7.02B and capital expenditures -2.19B, giving a free cash flow of 4.83B billion.
- Operating Cash Flow
- 7.02B
- Free Cash Flow
- 4.83B
- Free Cash Flow per Share
- 10.66
Dividends & Yields
Aspen Pharmacare pays an annual dividend of $0.12, resulting in a dividend yield of 1.29%
- Dividend Per Share
- $0.12
- Dividend Yield
- 1.29%
- Payout Ratio
- -51.89%
- Free Cash Flow Yield
- 6.12%
- Earnings Yield
- 3.34%
Stock Price Statistics
- Beta
- 0.20
- 52-Week Price Change
- 86.48%
- 50-Day Moving Average
- 9.62
- 200-Day Moving Average
- 8.77
- Relative Strength Index (RSI)
- 64.38
- Average Volume (3m)
- 7,725
Important Dates
Aspen Pharmacare upcoming earnings date is Mar 11, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Sep 02, 2026
- Next Earnings Date
- Mar 11, 2027
- Ex-Dividend Date
- Oct 03, 2025
Financial Position
Aspen Pharmacare as a current ratio of 2.54, with Debt / Equity ratio of 19.37%
- Current Ratio
- 2.54
- Quick Ratio
- 1.68
- Debt to Market Cap
- 0.23
- Net Debt to EBITDA
- -0.06
- Interest Coverage Ratio
- 3.51
Taxes
In the past 12 months, Aspen Pharmacare has paid 460.22M in taxes.
- Income Tax
- 460.22M
- Effective Tax Rate
- -1.12
Enterprise Valuation
Aspen Pharmacare EV to EBITDA ratio is 10.51, with an EV/FCF ratio of 16.26.
- EV to Sales
- 2.20
- EV to EBITDA
- 10.51
- EV to Free Cash Flow
- 16.26
- EV to Operating Cash Flow
- 11.19
Balance Sheet
Aspen Pharmacare has $15.87B in cash and marketable securities with $15.44B in debt, giving a net cash position of $425.58M billion.
- Cash & Marketable Securities
- $15.87B
- Total Debt
- $15.44B
- Net Cash
- $425.58M
- Net Cash Per Share
- $0.98
- Tangible Book Value Per Share
- $82.69
Margins
Gross margin is 40.31%, with operating margin of 15.48%, and net profit margin of 7.59%.
- Gross Margin
- 40.31%
- Operating Margin
- 15.48%
- Pretax Margin
- -1.20%
- Net Profit Margin
- 7.59%
- EBITDA Margin
- 20.98%
- EBIT Margin
- 15.48%
Analyst Forecast
The average price target for Aspen Pharmacare is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -13.45%
- EPS Growth Forecast
- ―
Scores
- Smart Score
- 6
- AI Score
- 68
